-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of investment in marketable security, classified as current.
-
Summary
-
Contineum Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2023 to Q2 2024.
- Contineum Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $141M.
Marketable Securities, Current, Quarterly (USD)